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 The conception of the Human Microbiome Project advanced the understanding of 
microbial communities in the human body and previous research has established that unique 
microbial signatures can help distinguish each body fluid. While these signatures have been 
developed for the prokaryotic microbiome, the next step is the examination of the eukaryotic 
microbiome. Eukaryotic signatures could provide a greater specificity and statistical weight 
when discerning between body fluids. These microbial markers can be implemented to develop a 
confirmatory assay for body fluid identification that works in tandem with other DNA based 
methods in the forensic workflow. Using a VCU approved IRB protocol, samples of urine 
(n=100), feces (n=72), and saliva (n=77) were collected. DNA was isolated and quantified using 
Qiagen’s QIAamp DNA Investigator and DNA Micro kits. The V9 region of the 18S rDNA was 
amplified using dual-index strategy and samples were sequenced on the Illumina MiSeq FGx. 
The sequences were analysed using Mothur (v 1.39.5) and RStudio (v 3.6.3). The relative 
abundance of eukaryote taxa and an Analysis of Molecular Variance (AMOVA) indicated 
significant differences in the eukaryotic community structure between all body fluids, except 
male and female urine. At the family level, feces was characterized by the combined presence of 
Saccharomycetaceae (80.1%). Malasseziaceae (37.4% male, 36.6% female) and Diptera (22.6% 
male, 19.4% female) were indicators for urine, while Poales (43.3%) and Asparagales (10.3%) 
indicated saliva. The species richness was greater in urine but less in feces and saliva when 
compared to the species richness of the prokaryotic microbiome. Overall, these results indicate 
that each body fluid has a unique eukaryotic community and potential for use in body fluid 
identification, especially as a compliment to the bacterial signatures that have already been 
developed. The results of this study are a novel addition to previous work, and advance the use 
of microbial forensics as an alternative method in forensic serology. 
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 The human microbiome, a complex community of microbial organisms consisting of 
bacteria, archaea, and eukaryotes, has come to the forefront of medical research in recent years 
due to the wealth of information that can be gained from studying what thrives in and on our 
bodies (1, 2). The Human Microbiome Project (HMP), formed in 2007, has furthered the 
understanding of how the host and the microbes interact and has characterized at least a portion 
of the communities that make up the microbiome (3). However, the HMP focuses more on the 
biomedical and physiological applications, rather than how it can be utilized for forensic 
purposes. Most of the research performed so far has been done with bacteria, by far the most 
prevalent microorganism in the human host, by targeting the 16S ribosomal RNA (rRNA) gene. 
Because of the difference in the relative abundance of bacteria versus eukaryotes within the 
microbiome, there have been fewer studies in the characterization of the eukaryotic communities 
using the 18S rRNA gene (4). 
Overview of Forensic Serology  
Forensic serology is the identification, classification, and study of body fluids as they 
relate to a crime. Identifying the body fluid found on evidence is a crucial part of a forensic 
investigation, as it guides a forensic analyst to the proper course of action for the evidence 
sample. Early scientific methods of blood identification date back to the late 1800’s, starting with 
an enzyme test that gave a reaction based on the peroxidase-like activity of hemoglobin (5). 
Body fluid identification usually begins with a screening to find areas of interest on larger pieces 
of evidence, typically with a chemical indicator or an alternate light source. A presumptive test is 
then performed that determines the likelihood that the substance is a particular fluid. Presumptive 
tests are subject to false positives because they rely on chemical reactions that occur in multiple 
6 
 
fluids or naturally in other substances (6). Finally, if one is available, a confirmatory test can be 
performed to positively identify a specific body fluid. True confirmatory tests are only available 
for blood, using either the Takayama crystal test or an antibody test, and semen, by microscopic 
identification or detection of the prostate specific antigen (PSA) (6). The current serological 
methods are rapid and low-cost, but are also non-specific and labor intensive. The current tests 
for saliva, urine and feces are all presumptive and employed in only about half of laboratories 
worldwide, according to a survey done by Desroches et. al. (2009) (6). As DNA analysis systems 
and technology have increased in sensitivity, the detection levels for serological techniques of 
most fluids have remained unchanged. 
New Methodologies for Serological Identification 
     
 Due to the nature of current serological methods, more research is being conducted in 
alternative methods of body fluid identification that work in tandem with DNA analysis. Several 
studies have been done on the use of messenger RNA (mRNA) profiling, where body fluids are 
identified by the gene expression of the cell types that comprise the specific fluid (7, 8). 
Messenger RNA profiling employs the use of reverse-transcription polymerase chain reaction 
(RT-PCR) for detection and is designed to multiplex with capillary electrophoresis (CE) systems 
(7). Another, similar technique is the expression of microRNAs (miRNAs), which are small 
sections of non-coding RNA, to identify body fluids. In multiple studies, miRNAs have been 
shown to be differentially expressed in forensically relevant body fluids (9)(10)(11). Subsequent 
studies have developed methods to incorporate this technique using RT-PCR and CE systems to 
generate miRNA expression data specific to each body fluid (12). Both of these methods do have 
some disadvantages. Messenger RNAs are more prone to degradation because of their longer 
sequences compared to miRNAs and miRNA quantitation has been proven to vary depending on 
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the method of detection (13). Until recently, the use of the human microbiome for body fluid 
identification has remained unexplored. 
Microbial Characterization of Body Fluids 
Ribosomal RNA genes are sequences of DNA which code for the RNA strands that 
comprise sections of the subunits in ribosomes. Because ribosomes are needed to manufacture 
proteins and can be found in all cells, the rRNA genes can be sequenced to determine an 
organism’s taxonomic group (14). Next-generation sequencing of rRNA genes, specifically the 
16S subunit in bacteria and the 18S subunit in eukaryotes, is the current and most reliable 
method for phylogenetic classification of the microbiome (15). The samples are each tagged with 
a different barcoded primer, amplified through PCR, and parallel sequenced. The sequenced 
strands are separated by barcode and compared to reference sequences in SILVA, a database 
comprised of aligned rRNA sequences from all three domains: Bacteria, Archaea, and Eukarya 
(15). Since the need for further research into the eukaryotic taxa became apparent, the 
development of universal primers for 18S rRNA genes has been a priority. Studies done by both 
Hadziavdic et. al. (2014) and Wang et. al. (2014) identified the most suitable and effective 
primers for use in microbial classification among eukaryotic groups (16, 17). In a study by 
Amaral-Zettler et. al., the V9 hypervariable region of the eukaryotic rRNA gene was targeted for 
amplification in order to study Protista diversity in ecologically distinct bodies of water (18). The 
V9 hypervariable region is used as a target because it is highly conserved among eukaryotes and 
there are substantial resources for reference comparison (1). 
Mammalian Blocking Primers 
 Specific primers that anneal to common eukaryotic sequences are used to amplify the V9 
hypervariable region (1). In addition to these primers, a mammalian blocking primer is used to 
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obstruct the amplification of the host (i.e. vertebrate) DNA by blocking either the annealing or 
elongation step during the PCR process. Annealing blockers compete with the normal primers 
for binding space while elongation blockers bind between amplification sites and prevent 
elongation. The elongation arrest primers have an additional C3 spacer on the 3’ end which 
inhibits elongation during amplification. The blocking primers have species-specific sequences 
to ensure that only the unwanted mammalian DNA is blocked (19). These blocking primers can 
greatly reduce the quantity of human DNA that gets amplified; however they cannot completely 
eliminate amplification of the host sequences.   
Eukaryotic Taxonomy 
 Taxonomy, which is the classification of the diversity of organisms, is the foundation on 
which biological knowledge is structured. Traditionally, taxonomy has been based on 
morphological diversity, but given the complexity of the eukaryotic domain there has been a 
shift from the classic four kingdoms proposed by Robert Whittaker in 1969 to a new system of 
six supergroups (20). While the bacterial classification database still has its own issues, it 
continues to outperform the eukaryotic classification database in terms of accurately identifying 
taxa, simply because bacteria have been more extensively studied by the scientific community. 
The most commonly used reference file for eukaryotic classification, SILVA NR v132, 
relies on a six-level system (Level 1 to Level 6), which corresponds to the classifications 
traditionally used at the Domain through Genus levels. This reference uses the UniEuk 
taxonomic framework for eukaryote sequence alignment and classification. UniEuk is an open-
source, universal taxonomic framework that incorporates the collective current findings of the 
research community (21). As with most databases of its kind, it is not a complete and still 
produces unclassified sequences. Given the current classification structure of eukaryotic 
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taxonomy, it is important to note that analysis of sequences with classification at the genus level 
is not as successful as that of the higher taxonomic levels.  
Summary of Previous Work 
 Because of the diversity and abundance of prokaryotes within the human microbiome and 
the well-established use of 16S rRNA genes for sequencing, the majority of researchers seeking 
to identify body fluids by their microbial signature have focused on the domain Bacteria. 
Specifically for forensic application, one study developed a bacterial signature for saliva by 
cross-validation against skin samples (22). Work done by Dobay et. al. (2019) determined that 
forensically relevant body fluids still retained their unique bacterial composition even after 
environmental exposure (23). Data analysis for 16S rDNA sequencing has been optimized to 
improve recognition of four different fluid types: oral, nasal, vaginal and fecal (24).  
The first phase of this study also focused on prokaryotic diversity; all of the forensically 
relevant body fluids were sampled, which included blood, saliva, urine, feces, semen, menstrual 
fluid, and vaginal fluid. Bacterial signatures were developed for all of the fluids, though the 
female intimate samples (vaginal fluid and menstrual blood) and semen could not be statistically 
differentiated from each other, as seen in the Dobay et. al. study (23). Additional analyses 
included limit of detection and mixture studies. 
Project Goals 
 Now that signatures are being developed for the prokaryotic microbiome, the next step is 
the examination of the eukaryotic microbes of the human body. The eukaryotic signature could 
provide a greater specificity and statistical weight when discerning between body fluids. The 
goal of this study is to sequence the V9 hypervariable region of the 18S rRNA gene in saliva, 
feces and urine in order to identify the eukaryotic taxa present in each body fluid and compare 
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the microbial communities of each fluid for the development of a statistical model for body fluid 
identification.     
Materials and Methods 
Sample Collection and DNA Extraction 
 All samples were collected for previous research, following a VCU approved IRB 
protocol (HM20002931). Saliva and feces samples were collected on sterile cotton swabs and 
stored at room temperature in swab boxes. About half of each swab was used for extraction. 
Liquid urine samples were stored at -80°C and 1ml of sample was used for extraction. Both the 
fecal (n=72) and saliva (n=77) samples were extracted using Qiagen’s QIAamp® DNA 
Investigator Kit (Hilden, Germany) on the Qiagen QIAcube® (Hilden, Germany). The samples 
were eluted in 50µl for feces and 30µl for saliva. The urine (n=100) samples were extracted 
using the QIAamp® DNA Micro Kit (Qiagen, Hilden, Germany) also on the QIAcube® and 
eluted into 20µl. Due to sequencing space and barcoding constraints, the number of analysed 
samples for each body fluid differed (Table 1). To ensure consistency and reliability throughout 
the process, associated extraction reagent blanks and mock communities were analysed and 
sequenced alongside the serological samples. The male and female urine samples were analysed 
separately to remain consistent with the 16S bacterial phase of this study. 
Bacterial DNA Quantification 
All samples were quantified using the Applied Biosystems QuantStudio™ Flex Real-Time PCR 
System and Software v1.3 (Thermo Fisher Scientific, Waltham, MA) using protocol as described 
in Seashols-Williams et al. (2018). The ZymoBIOMICSTM Microbial Community DNA Standard 




18S rDNA Amplification 
The target region for eukaryote DNA identification was the hypervariable region V9 of 
the 18S rRNA gene. The samples were barcoded then amplified on the Applied Biosystems 
VeritiTM 96-Well Thermal Cycler (Thermo Fisher Scientific, Waltham, MA) using the primers 
and an adapted protocol described by the Earth Microbiome Project 
(http://press.igsb.anl.gov/earthmicrobiome/protocols-and-standards/18s/) as well as the dual-
index strategy  described by Kozich et al. (25). Each primer set consists of an Illumina® adapter 
sequence so the DNA can attach to the MiSeq® flow cell, an eight nucleotide index sequence and 
a ten nucleotide pad/linker sequence to increase the melting temperature, a two nucleotide non-
complementary linker sequence (CG for forward primer and CA for reverse primer), and a 18S 
rRNA gene specific forward primer (V8_1391f: 5’- GTACACACCGCCCGTC -3’) and reverse 
primer (V9_EukBr: 5’- TGATCCTTCTGCAGGTTCACCTAC -3’) (18, 26). To prevent the 
host’s DNA from being amplified, mammalian blocking primer (Mammal_block_I-short_1391f) 
was used in an 8:1 ratio of blocking primer to forward/reverse primer for the master mix. The 
master mix included 12.5 µl of Promega 2X PCR master mix (Promega, Madison, WI), 1 µl (5 
pmol/µl) each of forward and reverse primers, and 4 µl (10 pmol/µl) of mammalian blocking 
primer. The amount of DNA added to each well in 1 µl was dependant on body fluid; 0.3 ng was 
added for saliva and feces, while 0.02 ng was added for both male and female urine. These inputs 
were based on the initial 16S bacterial phase of this study using the bacterial qPCR 
quantification results (27). Nuclease free water was added to give a final total volume of 25 µl. 
Gel Extraction and PCR Purification 
 After amplification, the samples were run on a 1.6% agarose gel using 3µl of PCR 
product to make sure the amplified DNA was of the expected size. If a sample yielded more than 
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one PCR product, the target band of 260bp was excised and the DNA purified from the gel using 
the QIAquick® Gel Extraction Kit (Qiagen, Hilden, Germany) according to the manufacturer’s 
protocol, with the remaining 22µl of PCR product and eluted at 50µl (28). All saliva and feces 
samples required gel extraction while the urine samples did not. All amplified PCR products 
were cleaned using the Agencourt® AMPure® PCR Purification Kit (Beckman Coulter, Brea, 
CA) according to the manufacturer’s protocol using 10µl of PCR product for the urine samples 
or gel extracted product for the saliva and feces samples and eluted in 35µl of elution buffer (29). 
After purification, the samples were quantified using the Qubit™ dsDNA HS Assay Kit on the 
Qubit® Fluorometer.  
MiSeq® Sequencing 
All clean, amplified 18S rRNA gene products were pooled in an equimolar concentration 
of 1ng/µl. Average inputs were used for reagent blanks and negatives; i.e. if the average input for 
the feces samples was 2µl, the associated reagent blanks and negative controls would be added to 
the pool at that volume. The completed library pool was then sequenced on the MiSeq FGX 
sequencing platform (Illumina Inc., USA) using the MiSeq 2X250 Reagent Kit v2 (Illumina Inc., 
USA) following the manufacturer’s protocol. There were two sequencing runs for this study, 
including 41 reagent blanks, 2 mock communities, 5 PCR negatives, and a total of 249 body 
fluid samples. 
Data Analysis 
 The sequence data was analysed in Mothur (v1.39.5), an open source data analysis 
program (30). A contig file was created to pair the forward and reverse reads and the sequences 
were then aligned using the SILVA NR v132 reference database.  The UCHIME program in 
Mothur was used to isolate and remove chimera and singleton sequences. A read threshold of 
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200 reads was set as a baseline; if a sample contained 200 reads or less, it was removed from 
analysis. The samples were classified and any unwanted taxa were removed to leave only the 
eukaryotes. This removal included Archaea, Bacteria, Vertebrata, which includes Mammalia 
(the host), and unknown or unclassified sequences. The family Aspergillaceae (Level 5), was 
found to be common in reagent blanks across all body fluids and was also removed. It was 
concluded that the reagent blank sequences were due to Aspergillaceae and not contamination. 
The taxonomy file was used to construct a relative abundance chart at the family level (Level 5). 
Taxa that contained less than 100 reads across all body fluids were grouped together as “Rare” 
taxa.  The Log10 of the relative abundance values was used to construct a heat map. Values of 0 
were changed to 0.001 for logarithmic transformation. The distribution of highly abundant taxa 
was used to determine possible predictor taxa for each body fluid. Alpha (α) and beta (β) 
diversity measurements were assessed in Mothur using operational taxonomic units (OTUs) and 
phylogenetic approaches. Alpha diversity was evaluated using OTUs at a 5% genetic distance. 
Beta diversity was tested using analysis of molecular variance (AMOVA), to determine 
significant differences between fluids, and visualized using principal coordinate analysis (PCoA) 
using weighted UniFrac distances. PCoA and heat map data were plotted using the ggplot2 
package in RStudio v3.6.3 (31).  
Results 
 After lineage removal of the host sequences (i.e. vertebrates) and unclassified sequences 
and after classification, the total number of samples dropped from 249 to 148 samples with a 
read count above the threshold. This accounted for a 21% loss in feces samples, a 61% overall 
loss in urine samples, and a 32.5% loss in saliva samples. The total number of reads for all 
samples after sequence clean-up was 841,875 reads. There was a large variation in the read count 
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across samples, ranging from 41,113 to 201 reads, with an overall average of 5,688 reads. Saliva 
and urine experienced an 87% and 84% loss in sequence reads, respectively, while feces had a 
49% loss in reads after sequence clean-up (Table 2). 
 The two mock communities, with 0.3ng and 0.02ng of DNA input, respectively, were 
expected to contain the yeast species Saccharomyces cerevisiae and Cryptococcus neoformans. 
Both mock communities contained the expected sequences and classified at the family level 
(Figure 1). After removal of Aspergilaceae and classification, five out of forty-one reagent 
blanks had read counts above threshold, all belonging to urine (Figure 2). The variety and 
relative abundance of taxa within the reagent blanks was similar to the profiles of the urine 
samples, indicating possible contamination. Thirteen associated urine samples were removed 
from analysis, contributing 11% to the overall percent loss of urine samples.  
General Sequence Characteristics 
 The total 841,875 sequences were classified into 27 phyla (Level 2), 53 classes 
(Level 3), 105 orders (Level 4), 138 families (Level 5), and 205 genera. At all levels, 1.86% of 
all reads were unclassified and could only be identified as eukaryote. It is important to note here 
that 2% of all reads classified as Incertae Sedis, which is Latin for “uncertain placement”. It is a 
taxonomic group that is essentially a placeholder for taxa whose broader relationships are 
unknown or not yet defined (32). 
Taxonomic Distribution of Sequences 
 At the family level (Level 5), the most abundant classified reads were different in taxa 
and relative abundance for each body fluid (Figures 3 and 4). For feces, the most abundant taxa 
were Saccharomycetaceae (80.1%), Malasseziaceae (3.2%), Incertae Sedis (3.1%), Poales 
(2.6%), and Caryophyllales (2.0%). The male and female urine samples shared the top two most 
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abundant taxa but differed afterwards. The male urine was comprised of Malasseziaceae 
(37.4%), Diptera (22.6%), Poales (9.7%), Saccharomycetaceae (4.1%), and Incertae Sedis 
(3.7%), while the most abundant taxa in female urine were Malasseziaceae (36.6%), Diptera 
(19.4%), Debaryomycetaceae (12.1%), Trichosporonaceae (7.0%), and Mucoraceae (5.4%). For 
saliva, Poales (43.3%), Asparagales (10.3%), Saccharomycetaceae (8.9%), Chromulinales 
(7.8%), and Debaryomycetaceae (7.6%) had the highest relative abundance. For further 
visualization purposes, a heat map was created to indicate possible predictor taxa for each body 
fluid at the family level (Level 5). Relative abundance was Log10 transformed and all taxa with 
0% relative abundance were changed to 0.001 for logarithmic transformation. Possible indicator 
taxa include Saccharomycetaceae for feces, Malasseziaceae and Diptera for urine, and Poales 
and Asparagales for saliva. 
Eukaryotic Diversity Measurements 
 The Inverse Simpson Index was used as a measure for α-diversity associated with each 
body fluid (Figure 5).  The index values begin at 1, indicating only a single species, and range to 
a value that would indicate perfect evenness and be equal to the number of present taxa. The 
average index values for each body fluid were 1.37 for feces, 2.42 for male urine, 1.54 for female 
urine, and 1.70 for saliva. Male urine showed the greatest amount of species richness and feces 
the least. 
Analysis of molecular variance (AMOVA) based on weighted UniFrac distances (β-
diversity) indicated significant differences in eukaryotic community structure between all body 
fluid types, except male and female urine samples (Table 2).  
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A two-dimensional principal coordinate analysis (PCoA) plot based on weighted UniFrac 
distances explained 3.18% of variation associated with this data set and showed some clustering 
of samples for each body fluid group; however distinct clustering and separation between 
different fluid samples was not observed (Figure 6). 
Discussion 
 This study utilized MiSeq sequencing of 18S rDNA to analyse the eukaryotic community 
structure of feces, urine and saliva. A high quantity of mammalian blocking primer, which is a 
species-specific oligonucleotide with a 3’ modification to prevent elongation of the host DNA 
during PCR amplification, was used to prevent host DNA amplification (33). However, it did not 
inhibit all host DNA amplification and in most samples a majority of the sequences were 
classified as class Mammalia which resulted in a 41% sample loss. This was demonstrated 
particularly in the urine samples, where there was an overall 61% loss in those samples after 
sequence clean-up, indicating that there may be more human DNA from potential sources such 
as skin cells than other eukaryotic DNA in that fluid. Percent sample loss in the remaining fluids 
was about half or less than half that of the urine samples, suggesting that there was less host 
DNA amplified in saliva and feces. 
 Another potential contributor to the greater loss of urine samples was the original DNA 
input of 0.02ng for both male and female samples. This input was carried over from the 16S 
bacterial phase of this study and based on bacterial quantitation (27). However, due to the 
relatively reduced presence of eukaryotes versus bacteria in the human microbiome, the low 
input of 0.02ng compared to the 0.3ng input used for saliva and feces could have prevented 
amplification of eukaryotic DNA other than that of the host. 
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 Additionally, as the samples were processed, there was a continual dilution of the PCR 
product from amplification to gel extraction, purification and sequencing. If the sample had a 
reduced eukaryotic community from the start, some of those sequences may have been lost with 
each step as the sample was diluted.  
Taxonomic Diversity of Body Fluids 
 The alpha diversity, or species richness, of feces and female urine were less than that of 
saliva and male urine, though male urine was the only fluid to have a significantly higher 
average species richness (Figure 5). When compared to the alpha diversity of the prokaryotic 
microbiome in these fluids, there was more species richness of bacteria in feces and saliva than 
eukaryotes, but less richness of bacteria than eukaryotes in urine (27). This indicates that 
possible eukaryotic indicator taxa for urine may be of more assistance in distinguishing body 
fluids in conjunction with bacterial signatures than those of feces and saliva.    
Both saliva and urine had more variation in eukaryotic taxa than feces, though each fluid 
shared at least one taxon in the top most abundant eukaryotes. As all of the studied fluids are a 
part of the digestive process, it stands to reason that they would all contain some common taxa 
between them, as demonstrated by the overlap of different body fluid samples in the PCoA plot 
(Figure 6). Saccharomycetaceae, a yeast family, was the most abundant in feces, but was also 
present at lower levels in both saliva and urine. Also known as “sugar fungus” or “brewer’s 
yeast”, these yeasts are very important for food production and fermentation and have been 
previously identified as part of the human gut microbiome (34). They are likely abundant in 
feces to assist with the decomposition of waste. Poales, another shared taxon, was the most 
prevalent in saliva and is a large order of flowering plants that includes grass families, such as 
rice, wheat and grain, and other plants such as flowering fruits (35). In addition, the second most 
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abundant taxa in saliva and more unique to the fluid is also an order of plants: Asparagales, 
whose taxa are more related by genetic sequence than by morphological structure. It is 
unsurprising that plant material, which makes up the majority of the food that humans consume, 
would be found in high abundance in the fluid that aids in breaking down food for digestion. In 
both male and female urine, Malasseziaceae, a fungal family, was the most abundant taxa, 
though it is shared between body fluids. Malassezia are yeast-like fungi known to be common on 
human skin that are sustained by fatty acids and can cause skin disease (36). The second most 
prevalent taxon in urine was Diptera, which is an order of flies. This was an unusual result and 
there is nothing in the current literature to suggest why this occurred so abundantly across urine 
samples or even in smaller amounts the other fluids.  
 All three fluids were found to be statistically significantly different from one another by 
AMOVA pair-wise comparison, with the exception of male and female urine. Unlike their 
bacterial 16S rDNA counterparts, male and female urine cannot be distinguished from each other 
by their eukaryotic communities, even though the variety of taxa within male urine was 
significantly higher than that of the female urine.  
Possible Predictor Taxa 
 After studying the relative abundance chart of each body fluid at the family level (Level 
5), it appeared as though each fluid has its own eukaryotic microbial signature (Figures 3 and 
4). When choosing taxa that might distinguish one fluid from another, it was important to choose 
taxa that were the most abundant and unique to the particular body fluid. Saccharomycetaceae 
was selected as the indicator taxa for feces, as it was notably more abundant than any other taxon 
in that fluid. Malasseziaceae and Diptera were chosen for urine because their combined 
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abundance was unique to that fluid. Poales, for its abundance, and Asparagales, for its 
uniqueness, were chosen as indicators for saliva. 
Conclusion 
 Overall, the significant differences found between feces, urine and saliva indicate that 
their eukaryotic characterization could be a useful complement to the previously developed 
bacterial signatures for body fluid identification. These results can be further applied by studying 
the effects of diluted, compromised or mixed fluid forensic samples on the species diversity 
found in each fluid. This is a novel step forward in understanding the human eukaryotic 
microbiome, but the general knowledge in this area is lacking in the scientific community. While 
the bacterial microbiome has been thoroughly reviewed, more research is needed to better 
understand and classify eukaryotes so that results produced from studies such as this are refined 
with greater accuracy. The ultimate purpose of this research is to develop a confirmatory assay 
combining both the bacterial and eukaryotic microbiomes for body fluid identification that works 
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Table 2. Summary of the ranges and averages sequence reads for each body fluid before and 






Table 3. P values of pair-wise AMOVA comparisons of each body fluid based on weighted 
UniFrac distances. Experiment-wise error rate = 0.05 and pair-wise error rate (Bonferroni) = 
0.00833333. Yellow indicates there is a significant difference between body fluids and blue 





Feces Saliva Urine Female
Saliva 0.00002*
Urine Female 0.00002* 0.00002*
Urine Male 0.00002* 0.00002* 0.05074




Figure 1. Relative abundance of taxa at the family level in two mock communities (positive 
controls). 
Each mock community represented the two different sample DNA input amounts of 0.3ng and 

































Figure 2. Relative abundance of taxa at the family level in urine reagent blanks. 
These five reagent blanks contained sequences after quality control measures (i.e. host sequence 
and Aspergillaceae removal). Read counts ranged from 561 to 35,046 reads. The wide variety 
and relative abundance of taxa in each were similar to the profile of the urine samples. Only the 










































Figure 3. Relative abundance of classified eukaryotes at family level (level 5).  















































Figure 4. Relative abundance of the most abundant classified eukaryotes at family level (level 5).  
For feces, the most abundant taxa is Saccharomycetaceae (80.1%). The male and female urine 
samples share the top two most abundant taxa, Malasseziaceae (37.4% male, 36.6% female) and 
Diptera (22.6% male, 19.4% female). For saliva, Poales (43.3%) and Asparagales (10.3%) have 











































Figure 5. Inverse Simpson Index body fluid comparisons. 
Alpha diversity of the eukaryotic communities within each body fluid. The black bar within each 






Figure 6. Principle coordinate analysis using weighted Unifrac distances 
Beta diversity of the eukaryote communities for each body fluid. The first two axes explain 
2.04% and 1.14% of the variation in the original dissimilarity matrix, respectively. There is slight 






Mothur Commands & Options 























































































































Tests for (-diversity): 
 
amova(phylip=18S_BfID.pick.pick.pick.pick.phylip.tre1.weighted.phylip.dist
, design=AD_design_file.design, sets=all, iters=50000) 
pcoa(phylip=18S_BfID.pick.pick.pick.pick.phylip.tre1.weighted.phylip.dist) 
nmds(phylip=18S_BfID.pick.pick.pick.pick.phylip.tre1.weighted.phylip.dist, 












coaw) + xlab("Axis 1 (2.04%)") + ylab("Axis 2 (1.14%)") + theme() + 
theme(axis.line = element_line(colour = "black"),panel.grid.minor = 







row.names (dlevel5) = dlevel5$taxon 
dlevel5= dlevel5 [2:149] 
dlevel5_matrix = data.matrix (dlevel5) 
heatmap.2 (dlevel5_matrix,Rowv=FALSE, Colv=FALSE, 
scale="none",cexRow=0.5,cexCol=0.3,margins=c(8,12),  key=TRUE, 
keysize= 1.0, symkey=FALSE, trace="none",, density.info="none", 
col=brewer.pal(9,"YlGnBu")) 
heatmap.2 (dlevel5_matrix,Rowv=TRUE, Colv=FALSE, 
scale="none",cexRow=0.5,cexCol=0.3,margins=c(8,12),  key=TRUE, 
keysize= 1.0, symkey=FALSE, trace="none",, density.info="none", 
col=brewer.pal(9,"YlGnBu")) 
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